DE | Accessible presentation
Translations are powered by AI

How Munich biotech startups are fighting cancer

Munich is one of Germany's leading biotech hubs. Research is being conducted here on a wide variety of drugs and therapies, including cancer treatments. We'll introduce you to five startups in more detail.

February 21, 2023

Medical technology
The startup, founded in 2015 by Pascal Schweizer, Martin Hossann and Lars Lindner, Thermosome is developing a new method for delivering drugs precisely to their intended location in the body. The drug delivery platform technology is based on temperature-sensitive nanocarriers, known as thermosomes. Using a special device, Thermosome slightly heats a tumor compared to the surrounding tissue, so that the intravenously administered drugs only release their active ingredients there. This protects healthy tissue. Compared to conventional drug administration, this should achieve up to 15 times higher local drug concentrations in the diseased tissue. Thermosome's investors include High-Tech Gründerfonds and Bayern Kapital, which most recently injected €1.9 million into the startup in April 2016.
read more ↓